Journal of Translational Medicine (Sep 2018)

MAGIC: once upon a time in consent management—a FHIR® tale

  • Martin Bialke,
  • Thomas Bahls,
  • Lars Geidel,
  • Henriette Rau,
  • Arne Blumentritt,
  • Sandra Pasewald,
  • Robert Wolff,
  • Jonas Steinmann,
  • Tobias Bronsch,
  • Björn Bergh,
  • Galina Tremper,
  • Martin Lablans,
  • Frank Ückert,
  • Stefan Lang,
  • Tarik Idris,
  • Wolfgang Hoffmann

DOI
https://doi.org/10.1186/s12967-018-1631-3
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background The use of medical data for research purposes requires an informed consent of the patient that is compliant with the EU General Data Protection Regulation. In the context of multi-centre research initiatives and a multitude of clinical and epidemiological studies scalable and automatable measures for digital consent management are required. Modular form, structure, and contents render a patient’s consent reusable for varying project settings in order to effectively manage and minimise organisational and technical efforts. Results Within the DFG-funded project “MAGIC” (Grant Number HO 1937/5-1) the digital consent management service tool gICS was enhanced to comply with the recommendations published in the TMF data protection guideline for medical research. In addition, a structured exchange format for modular consent templates considering established standards and formats in the area of digital informed consent management was designed. Using the new FHIR standard and the HAPI FHIR library, the first version for an exchange format and necessary import-/export-functionalities were successfully implemented. Conclusions The proposed exchange format is a “work in progress”. It represents a starting point for current discussions concerning digital consent management. It also attempts to improve interoperability between different approaches within the wider IHE-/HL7-/FHIR community. Independent of the exchange format, providing the possibility to export, modify and import templates for consents and withdrawals to be reused in similar clinical and epidemiological studies is an essential precondition for the sustainable operation of digital consent management.

Keywords